Today's Washington Post Business section has an article regarding the potential return for investors as Celera prepares to complete its human genome research. http://www.washingtonpost.com and then scroll down to 'A Gene Dream'
http://www.washingtonpost.com and then scroll down to 'A Gene Dream'
Kathryn Aegis